Immune markers for monitoring the progression of autoimmune disease

Diabetes Metab Res Rev. 1999 Mar-Apr;15(2):141-5. doi: 10.1002/(sici)1520-7560(199903/04)15:2<141::aid-dmrr19>3.0.co;2-a.

Abstract

The incidence of immune-mediated diseases is increasing worldwide. Reliable immune markers for monitoring disease progression and also the effect of therapeutic interventions are urgently needed in order to investigate preventive or therapeutic measures effectively. At a recent workshop held on 5 December 1998 in Copenhagen, the state of research on surrogate markers in Type 1 diabetes was discussed and compared with the experience in multiple sclerosis, inflammatory bowel disease and transplantation.

Publication types

  • Congress
  • Review

MeSH terms

  • Autoimmune Diseases / epidemiology
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / physiopathology*
  • Biomarkers / analysis*
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Disease Progression
  • Global Health
  • Humans
  • Incidence
  • Inflammatory Bowel Diseases / immunology
  • Inflammatory Bowel Diseases / physiopathology
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / physiopathology
  • Transplantation Immunology

Substances

  • Biomarkers